Skip to main content

Table 2 Cox regression analyses of post-treatment antibodies and disease-free survival

From: Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer

 

HR

95% CI lower

95% CI upper

P value

Arm B

0.234

0.05

1.87

0.06

Arm C

0.197

0.044

0.883

0.03

∆RI1 (A,B,C)

0.23

0.056

0.941

0.04

  1. Cox regression analysis. 1∆RI = change in antibody RI from pre- to post-treatment in all patients (N = 50). HR hazard ratio, CI confidence interval